Find Clinical Trial

PRotelos 2g in the OSteoporosis treatment, the Tolerability and Efficacy Profile – PROSTEP

← Back
Study Phase

Phase 4

Therapeutic Area


SponsorServier s.r.o.
Active substance/
Medical device


Active Substance CodeS012911
Protocol CodeIC4-12911-098
EudraCT Code2005-004986-41

Documents and links

Scientific publication READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.